Findings of clinical trials that evaluate the impact of medical therapies on progression of atherosclerosis

Andrea Lavoie, Kiyoko Uno, Ozgur Bayturan, Stephen J. Nicholls

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)


Arterial wall imaging has been increasingly employed in clinical trials to evaluate the impact of medical therapies on progression of atherosclerosis. A selective overview of major findings from clinical trials that assessed the impact of medical therapies on atherosclerosis progression. Targeting established risk factors including LDL cholesterol, HDL cholesterol and blood pressure has a beneficial impact on disease progression. As a result, vascular imaging has been employed in the early evaluation of experimental therapies.

Original languageEnglish
Pages (from-to)745-751
Number of pages7
JournalCurrent Medical Research and Opinion
Issue number3
Publication statusPublished or Issued - Mar 2010


  • Atherosclerosis
  • Clinical trials
  • Imaging
  • Prevention
  • Risk factors

ASJC Scopus subject areas

  • Medicine(all)

Cite this